Market Pathways | MedTech Regulatory & Policy

Exploring the people, challenges, and opportunities impacting the global #medtech regulatory, reimbursement and policy communities. Likes,RTs,etc ≠ endorsement.

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

⚕ MedTech regulatory, reimbursement and #policy made easy.

We are global medical device market-access experts researching, writing and sharing the knowledge you need to keep you informed and ahead of your competition in the #medtech industry.

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Generative #AI may need a medical license, not a device clearance. A new proposal suggests regulating autonomous #healthcare AI more like physicians, with exams, supervised training, and ongoing oversight: https://t.co/zaJgI4ieOv

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Stop digging through dozens of #regulatory websites. Pathways Document Depot puts global #medtech policy, guidance, reports, and regulatory documents in one searchable database: https://t.co/SU9gkWXV2K

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

The 3FDA got off to a strong start in 2026. Q1 saw the highest number of novel #medtech device approvals since at least 2019, with continued growth in 510(k) clearances and PMA supplements.

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Keeping up with #medtech policy and reimbursement changes can feel like a full-time job. The Market Pathways Podcast makes it easier with real conversations and practical insights from industry experts. Get access here: https://t.co/Ak7AaQxF9Y

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

#FDA approval is only part of the challenge. Coverage is the other half of the equation.

“If it's successful, you get your FDA approval, you get coverage.”

Big discussion around RAPID at #InnovationDublin: https://t.co/4WDMhFCzQH

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Struggling with #MDR/IVDR classification? The updated EU Borderline & Classification Manual (v5, April 2026) offers key guidance. Explore it and access more in Pathways’ Document Depot: https://t.co/F7mqsqApo5

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Leading in #medtech starts with insight.

Market Pathways delivers global analysis on #regulatory, reimbursement, and policy trends so you can stay ahead and make smarter decisions: https://t.co/IK6xDfPcVf

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

The shift is here, and many aren’t ready. Regulators are now analyzing device safety data and expect manufacturers to do the same. Why 2026 is a turning point for surveillance: https://t.co/lhplI3uiHR #medtech

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Faster coverage is the goal, but questions remain. @FDADeviceInfo and @CMSGov introduce RAPID to align approval and #Medicare coverage for Breakthrough Devices. Industry is watching closely as details unfold: https://t.co/aUN3gkyWnq #medtech

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Postmarket surveillance is evolving fast. Regulators now expect manufacturers to actively analyze device safety data, not just submit it. Read more here: https://t.co/A64NtnfMBq #medtech

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

The conversations shaping #medtech are happening here. Get access to the Market Pathways Podcast for insights on global regulation, #reimbursement, policy, and market access: https://t.co/kmFC0lj9m9

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Policy shifts shape #medtech long before headlines do. Market Pathways delivers the regulatory, reimbursement, and #policy insight professionals use to stay ahead. Learn more here: https://t.co/7FEIv1woEG

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

The #FDA approval pathway is evolving. At #InnovationDublin 2026, @joshatstanford and Steve Farmer debated whether pivotal trials can also meet Medicare coverage standards. A major conversation for #medtech market access: https://t.co/xwQgxWQg8H

[U.S. FDA @US_FDA]

Attn: Industry partners — FDA heard you. We're extending the comment period on the Real-Time Clinical Trials Pilot Program Request for Information to June 29. Help shape the future of clinical research. Submit today!

🔗 https://t.co/AUuhLnrAPM

#RealTimeClinicalTrials

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Global #medtech policy activity is accelerating. Pathways’ Document Depot tracked 159 policy docs from 26 agencies in Mar/Apr 2026, with major movement in AI, software, and #regulatory reform worldwide: https://t.co/u0sGX3opFZ

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Market Pathways covers the regulatory, #reimbursement, and policy developments shaping commercialization strategies across the global #medtech industry: https://t.co/C3loujzrY3

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Getting a device to market is becoming more complicated from every angle.

Regulatory strategy, #reimbursement planning, and market access expectations are all evolving at once

What do you think is creating the biggest barrier for #medtech companies right now?

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

The smartest professionals in #medtech know where to look first. Pathways’ Document Depot gives you searchable access to global #regulatory and policy documents all in one place. Get access here: https://t.co/D9o8Pm4l2H

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

The #FDA approval pathway is evolving. At #InnovationDublin 2026, @joshatstanford and Steve Farmer debated whether pivotal trials can also meet Medicare coverage standards. A major conversation for #medtech market access: https://t.co/xwQgxWQg8H

[Market Pathways | MedTech Regulatory & Policy @Market_Pathways]

Policy shifts shape #medtech long before headlines do. Market Pathways delivers the regulatory, reimbursement, and #policy insight professionals use to stay ahead. Learn more here: https://t.co/7FEIv1woEG